Requesting The Auditor To Assess The Social And Financial Effects Of Mandating Health Insurance Coverage For Oocyte Cryopreservation.
Impact
The impact of SCR152, if enacted, would lead to a comprehensive review involving the state auditor, who is tasked with studying the potential social and financial impacts of mandating insurance coverage for oocyte cryopreservation. This includes a survey of other states that have enacted similar mandates, which could uncover various outcomes regarding accessibility, cost implications, and overall effectiveness of such measures. The auditor is also instructed to explore definitions relating to 'reproductive age' and to consider successful outcomes across different age demographics to inform any potential health coverage limitations that might ensue.
Summary
SCR152, introduced in the Thirty-first Legislature of Hawaii in 2022, requests an assessment by the state auditor regarding the social and financial effects of mandating health insurance coverage for oocyte cryopreservation, commonly known as egg freezing. The resolution arises from concerns over infertility risks faced by women undergoing certain medical procedures such as chemotherapy or surgeries that may affect ovarian function. Currently, health insurers in the state are not required to cover oocyte cryopreservation procedures, which has prompted legislative considerations for mandated coverage. The resolution seeks to evaluate the implications of such coverage, including comparisons to other states with similar mandates.
Sentiment
The sentiment surrounding SCR152 reflects a growing awareness of infertility issues affecting women, particularly in the wake of medical treatments that pose risks to reproductive health. Supporters of the resolution advocate for enhanced access to reproductive health services through mandated insurance coverage, expressing the idea that financial barriers should not prevent women from securing necessary medical interventions. However, there may also be concerns regarding the financial implications for health insurers and the costs associated with such mandates, which could lead to a polarized debate. Discussions around reproductive health often engage a range of perspectives about personal choice, healthcare rights, and insurance responsibilities.
Contention
Notable points of contention surrounding SCR152 may arise regarding legal and ethical considerations of oocyte cryopreservation. The auditor is also instructed to examine aspects such as the legal rights of individuals over their stored eggs, including what happens upon death or separation of donors. These complex legal issues may affect the overall reception of the proposed mandate for insurance coverage, as stakeholders from various fields – including healthcare, insurance, and legal entities – likely weigh in on how to navigate these sensitive circumstances. This multi-faceted inquiry signifies the intersection of health policy, personal rights, and the evolving landscape of reproductive health.
Requesting The Auditor To Conduct A Social And Financial Assessment Of Proposed Mandatory Health Insurance Coverage For Step Therapy Requirements For Stage Two Through Stage Five Cancer.
Requesting The Auditor To Conduct A Social And Financial Assessment Of Proposed Mandatory Health Insurance Coverage For Step Therapy Requirements For Stage Two Through Stage Five Cancer.
Requesting The Auditor To Assess Both The Social And Financial Effects Of Proposed Mandated Health Insurance Coverage For A Percentage Of The Costs Of Ketamine Therapy To Treat Depression And Suicide Ideation.
Requesting The Auditor To Assess Both The Social And Financial Effects Of Proposed Mandated Health Insurance Coverage For A Percentage Of The Costs Of Ketamine Therapy To Treat Depression And Suicide Ideation.
Requesting The Office Of The Auditor To Conduct A Performance Audit Of The Plant Pest Control Branch And Plant Quarantine Branch Within The Plant Industry Division Of The Department Of Agriculture.
Requesting The Auditor To Assess The Social And Financial Effects Of Mandatory Health Insurance Coverage For Fertility Preservation Procedures For Certain Persons Who Have Been Diagnosed With Cancer And Whose Cancer Or Cancer Treatment May Adversely Affect Their Fertility.
Requesting The Auditor To Assess The Social And Financial Effects Of Mandatory Health Insurance Coverage For Fertility Preservation Procedures For Certain Persons Who Have Been Diagnosed With Cancer And Whose Cancer Or Cancer Treatment May Adversely Affect Their Fertility.